Steven Copenhaver
Pediatric Pulmonology · Dallas, TXNPI 1396784518
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (48.5%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. Sobi, Inc accounts for 63.3% of it on its own, with 30 other manufacturers making up the rest. Reporting peaked in 2019 at $8,141 and has fallen 89.9% since, to $818 in 2025. Among pediatric pulmonology clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 273 payments — averaging $48.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sobi, Inc$8K
- AstraZeneca$863
- Regeneron Healthcare Solutions, Inc.$764
- Sanofi$428
- Covis Pharma GmbH$396
- Philips North America LLC$357
- plus $2K from 25 others
What the payments were for
- Consulting fees$1,2309%
- Speaking & faculty fees$6,35548%
- Food & beverage$5,28540%
- Education$2342%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sobi, Inc | 24 | $8,298 |
| AstraZeneca | 52 | $863 |
| Regeneron Healthcare Solutions, Inc. | 26 | $764 |
| Sanofi | 14 | $428 |
| Covis Pharma GmbH | 22 | $396 |
| Philips North America LLC | 25 | $357 |
| AbbVie | 22 | $298 |
| Electromed, Inc. | 16 | $241 |
| Baxter Healthcare | 9 | $222 |
| Insmed, Inc. | 8 | $167 |
| GSK | 9 | $131 |
| Novartis | 7 | $127 |
| Chiesi USA, Inc. | 5 | $105 |
| Amgen | 4 | $87 |
| Sanofi-aventis U.S. LLC | 4 | $81 |
| Acadia Pharmaceuticals Inc | 3 | $72 |
| Alcresta Therapeutics, Inc. | 2 | $62 |
| Sanofi Pasteur Inc. | 3 | $61 |
| Genentech USA, Inc. | 3 | $52 |
| Pharming Healthcare, Inc. | 2 | $45 |
| Boehringer Ingelheim | 2 | $39 |
| Mylan Specialty L.p. | 2 | $36 |
| Pfizer | 1 | $24 |
| Monaghan Medical Corporation | 1 | $23 |
| Tactile Systems Technology Inc | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Azurity Pharmaceuticals, Inc. | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Olympus America Inc. | 1 | $17 |
| PARI Respiratory Equipment, Inc. | 1 | $16 |
| Merck | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Synagis$7,800
How this compares
$13,103 in reported general payments places this provider in the 90th percentile of 104 pediatric pulmonology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Advair HfaFluticasone Propion/Salmeterol | 12 | $3,507 |
Paid to pharmacies, not to this prescriber.
Other pediatric pulmonology in Dallas
- Carolyn CannonDallas$55K
- Preeti SharmaDallas$10K
- Syed NaqviDallas$7K
- Andrew GelfandDallas$6K
- Pravin SahDallas$5K
- Yadira Rivera-SanchezDallas$3K
- Folashade AfolabiDallas$3K
- Devika RaoDallas$1K
- Michelle CaraballoDallas$693
- Brian MahmoodDallas$499
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.